Skip to main content
Journal of Cancer Research and Clinical Oncology logoLink to Journal of Cancer Research and Clinical Oncology
. 1999 Jun;125(7):402–404. doi: 10.1007/s004320050293

Antioxidant enzyme activities and lipid peroxides in the plasma of patients with benign prostatic hyperplasia or prostate cancer are not predictive

Semra Dogˇru-Abbasogˇlu 1, Gülçin Aykaç-Toker 1, Taner Koçak 2, Erdinç Ünlüer 3, Müjdat Uysal 1
PMCID: PMC12199823  PMID: 10394960

Abstract

In this study, lipid peroxide and total sulfhydryl contents and activities of superoxide dismutase (SOD), glutathione peroxidase (GPx), and catalase (CAT) were investigated in the plasma of patients with benign prostatic hyperplasia (BPH) and prostate cancer. No significant change was found in lipid peroxidation or antioxidant systems in the plasma of patients with BPH and prostate cancer. The results indicate that evaluation of the prooxidant-antioxidant balance in the plasma of BPH and prostate cancer patients cannot be used as a marker to discriminate between these diseases.

Keywords: Key words Benign prostatic hyperplasia, Prostate cancer, Lipid peroxides, Antioxidant enzymes, Plasma

Footnotes

Received: 5 November 1998 / Accepted: 19 January 1999


Articles from Journal of Cancer Research and Clinical Oncology are provided here courtesy of Springer

RESOURCES